TYSABRI (natalizumab) injection, for intravenous use. Initial U.S. Approval: 2004

FDA approved Anti-Cancer medicine TYSABRI (natalizumab) injection is available upon request. Get best retail price of TYSABRI (natalizumab) injection from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Neurologist.
TYSABRI (natalizumab) injection, for intravenous use. Initial U.S. Approval: 2004
TYSABRI (natalizumab) injection, for intravenous use
Category: .

TYSABRI (natalizumab) injection, for intravenous use. Initial U.S. Approval: 2004

INDICATIONS AND USAGE
TYSABRI is an integrin receptor antagonist indicated for treatment of:
Multiple Sclerosis (MS)
• As monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy.
Crohn’s Disease (CD)
• Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn’s disease with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of TNF-α.
DOSAGE FORMS & STRENGTHS: Solution [300 mg per 15 mL vial] for dilution prior to infusion.
Manufactured By: t Biogen Idec or Elan
Prescribing Information URL: Click Here

HOW TO MAKE AN ENQUIRY FOR TYSABRI (natalizumab) injection?

FDA approved Anti-Cancer medicine TYSABRI (natalizumab) injection is available upon request. Get best retail price of TYSABRI (natalizumab) injection from trusted online pharmacy. For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email [email protected]. For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with Neurologist.

Description

Natalizumab, sold under the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. It is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. It is given by intravenous infusion every 28 days.

HOW AND WHERE TO BUY natalizumab injection?

You can order natalizumab injection direct from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery. To get best retail price/cost of natalizumab injection for injection in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

Prev
Next
neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    Get Access to TYSABRI (natalizumab) injection In India

    Medvitaz Pharma is a Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer of Anti-Cancer Medicines / Drugs, used in Multiple Sclerosis (MS) Crohn’s Disease (CD) treatment from India. Submit the request form for cost price of Brand Name “REZUROCK (belumosudil) tablets” or Generic Name “natalizumab injection” can be imported for personal use under “patient name basis” treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Once we review your request and delivery process, we’ll send you an estimated price for the medicine within 1-2 days.

    You may be interested in

    OCREVUS ™ (ocrelizumab) injection
    OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017
    ZEPOSIA ® (ozanimod) capsules, for oral use
    ZEPOSIA (ozanimod) capsules, for oral use. Initial U.S. Approval: 2020